Group items tagged

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication of semaglutide (Wegovy), authorising its use to reduce the risk of serious heart problems and strokes in adults who are obese or overweight. Semaglutide, a GLP-1 receptor agonist, was previously approved for use in the treatment of obesity and weight management, to be used alongside diet, physical activity and behavioural support. The latest approval establishes it as the first weight loss drug to be prescribed to prevent cardiovascular events, such as cardiovascular death, non-fatal heart attack and non-fatal stroke, in people with established cardiovascular disease and a Body Mass Index (BMI) higher or equal to 27 kg/m2. Novo Nordisk, the manufacturer of Wegovy, received this authorisation on 23 July following compelling evidence from a recent post-approval clinical study involving over 17,600 participants. The study demonstrated that Wegovy, administered at a dose of 2.4 mg once weekly via subcutaneous injection for up to five years, significantly lowers the incidence of major adverse cardiovascular events (MACE) by 20 per cent compared to a placebo.

On World Head and Neck Cancer Day today (27 July), the National Health Service (NHS) has launched a new partnership with the British supermarket chain, Asda to raise awareness of mouth cancer symptoms. As part of this partnership, the NHS will provide vital advice on millions of toothpaste tubes and mouthwash bottles, urging people to consult their GP or dentist if they notice any potential symptoms of mouth cancer. Starting this month, the grocer's own brand of oral hygiene products will feature NHS advice in over 500 Asda stores nationwide. The NHS guidance will be displayed on the packaging, along with a link to more detailed information about mouth and throat cancer on the health service website. Professor Peter Johnson, national clinical director for cancer at NHS England, said: "Early detection of mouth cancer can help save lives and this fantastic new partnership with Asda will be vital in raising awareness of the signs and in supporting the NHS's ambition to diagnose more cancers at an earlier stage.

People are advised to be mindful of medications that may cause sun reactions, and to watch out for dodgy hay fever treatments and fake weight loss pens. For those traveling abroad, the MHRA advises considering the suitability of medicines available to reduce the risk of contracting tropical diseases. Dr Alison Cave, Chief Safety Officer at the MHRA, said: "The summer is an exciting time for many of us, as we take time off to travel and enjoy the warmer weather. "But it is important to understand what this time of year means for our medicines and medical devices, and take the precautions necessary to use products safely and protect ourselves." Watch out for dodgy hay fever treatments Millions of Britons suffer from hay fever symptoms in the summer. The MHRA advises consulting a healthcare professional to find the best treatment for your symptoms. People are also warned to be cautious of medicines advertised as hay fever treatments but not approved for use in the UK, such as Kenalog. This is a prescription-only steroid injection licensed as a medicine for other conditions, but not for the treatment of hay fever.

Following the publication of a new study by the British Medical Journal (BMJ) that estimates the economic impact and prevelance of hazardous NSAID prescribing in England, the Royal Pharmaceutical Society (RPS) has underscored the pressing need for enhanced safety measures in medication management. The study, led by RPS Fellow Rachel Elliott, reveals significant health and financial costs associated with the high-risk prescribing of oral non-steroidal anti-inflammatory drugs (NSAIDs) among vulnerable populations. James Davies, Director for England at the RPS, emphasised the critical findings of the research. "Improving the safety of NSAID prescribing requires a multi-pronged approach, that educates and supports prescribers on the risk, as well as uses the skills of pharmacists in the primary care team to help identify higher risk patients and prescribing scenarios," Davies remarked. The study highlights that NSAIDs, while effective in managing pain and inflammation, are associated with serious adverse events, including gastrointestinal bleeding, renal dysfunction, and cardiovascular issues.

Personal injury law, being a set of legal provisions and procedures, can often be difficult to understand; however, knowing the fundamentals is an entirely different game and can greatly impact your claim. If you have a small wound or a car accident, understanding your rights as the victim as well as the best course of action to take is essential. This is what you should know if you want to protect yourself. Documentation About Injury The documentation process is very crucial in ensuring that you win a personal injury case. This consists of maintaining receipts for medical expenses, treatment receipts, and any communication made to do with your injury. You can also use photographs as proof, such as pictures of your injuries, the site of the accident, or the extent of the property damage. Additional information in the form of specifications on how the injury has impacted your daily life, employment, and even mental health enhances the application. This kind of evidence can go a long way in pressuring an insurance company or a judge to take your injuries seriously. Every piece of documentation related to the injury is important, but it is critical to have help on how to format it while filing for the claim. A personal injury attorney must be hired as soon as possible because they play a major role in determining the results of the case. It is always recommended to consult with an attorney who has extensive experience handling these types of claims, as it is critical to adhere to all legal guidelines and procedures. Not only can they explain the general legal proceedings to you but they can also do all the negotiations with insurance companies for you and even defend you in court if required to do so.

There is a clear opportunity for community pharmacists and their teams to lead best practice when it comes to supporting the ongoing health needs of older people. As the global population continues to age, the demand for specialised healthcare services tailored to the elderly is rapidly increasing. Community pharmacists, with their accessible locations and frequent interactions with patients, are uniquely positioned to play a pivotal role in addressing this growing need. The ageing population presents a complex set of health challenges, including multiple chronic conditions, polypharmacy, and increased susceptibility to adverse drug reactions. Community pharmacists, armed with their extensive knowledge of medications and their effects, can serve as the first line of defence in managing these issues. By leveraging their expertise, they can implement best practices that not only improve the quality of life for older individuals but also reduce the burden on the broader healthcare system. One of the primary areas where community pharmacists can make a significant impact is in medication management. As people age, they often find themselves taking multiple medications for various conditions. This polypharmacy can lead to dangerous drug interactions, side effects, and compliance issues. Community pharmacists can lead the way in implementing comprehensive medication reviews, ensuring that each patient's drug regimen is optimised for their specific needs and minimising potential risks.

"Not possible for pharmacists to check whether prescriptions issued from overseas registered prescribers have been issued in a similarly safe and effective way," the new Minister of State (Department of Health and Social Care) Karin Smyth said during a recent parliamentary written response. At a recent session on Monday, July 29th, at the House of Commons, MP Cat Smith raised an important question directed at the Secretary of State for Health and Social Care. Smith, who represents Lancaster and Wyre, and has been an MP continually since 7 May 2015, inquired about whether the Department of Health and Social Care had conducted a comparative assessment of the UK's stance on prescribing puberty blockers for treating gender incongruence in comparison to other European countries. Responding to the questions, MP Karin Smyth emphasised on the significance of the Cass Review and described it as one of the most thorough examinations conducted across the globe on gender identity services for children and young people.

The Pharmacists' Defence Association (PDA) has welcomed the Chancellor's announcement of a 5.5 percent pay increase for NHS pharmacists. Following the acceptance of the NHS Pay Review Body's (PRB) recommendations, Chancellor Rachel Reeves shared the announcement in a speech to Parliament on 29 July. She confirmed that the pay review bodies' recommendations for health and education for 2024-25 would be fully implemented. Reeves' speech came alongside the release of her audit into public finances, a commitment she made shortly after the recent election. The audit confirms that the recommendations from various PRBs, including those for NHS staff, doctors, dentists, teachers, and other public servants, have been approved and will be acted upon. "That is the right decision for the people who work in and most importantly the people who use our public services…giving hardworking staff the pay rise they deserve while ensuring we can recruit and retain the people we need," Reeves announced.

Customs officials at Mundra port in Gujarat's Kutch district, India, recently seized approximately 6.8 million Tramadol tablets valued at Rs 110 crore (around GBP 10.2 million). The tablets were discovered in two export containers bound for Sierra Leone and Niger in West Africa. Tramadol, an opioid pain medication, was classified as a psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act (NDPS Act) in 2018 and its export is now restricted. This synthetic opioid drug has gained notoriety in recent times as the "Fighter Drug" after it was reported that ISIS fighters used it to stay awake for long hours, said a PIB release on Monday. It is reportedly in high demand in African nations like Nigeria, Ghana, etc. The Mundra Customs seizure is one of the largest seizures of Tramadol since it was notified under the NDPS Act, said the release.

Health and Social Care Secretary, Wes Streeting, visited St Margaret's Hospital in Epping, West Essex, on Thursday (1 August) as part of an ongoing series of planned engagements with NHS trusts across England. Accompanied by NHS Chief Executive, Amanda Pritchard, Streeting observed how NHS staff are using innovative technology to monitor patients at home and prevent unnecessary hospital admissions. He met with staff from the hospital's Care Coordination Centre and the 'hospital at home' hub, which work to reduce unnecessary A&E admissions and facilitate quick and safe discharges home. Before the hospital tour, the health secretary met the trust's falls response team, which uses a specially equipped 'falls car' to assist patients who have fallen at home, preventing A&E visits. Later, Streeting visited the Ross Practice GP surgery in Harlow before holding a town hall event with health leaders in the region.

The government has accepted the Joint Committee on Vaccination and Immunisation's (JCVI) advice for the autumn 2024 COVID-19 vaccination programme. According to the JCVI, the following groups will be eligible for vaccination this autumn: Individuals aged 65 and over Residents of care homes for older adults Those aged 6 months and older in clinical risk groups Minister for Public Health and Prevention, Andrew Gwynne, emphasised the importance of protecting vulnerable populations from COVID-19 and reducing pressure on the NHS. He said: "We are committed to protecting those most vulnerable from COVID and have accepted the independent advice from the JCVI for the autumn 2024 vaccination programme." "I encourage anyone invited for a vaccine to get one as soon as possible to protect yourself and reduce pressure on the NHS during winter, helping to cut waiting times and get the health service back on its feet."